Mirae Asset Global Investments
LXEO icon

Mirae Asset Global Investments’s Lexeo Therapeutics LXEO Stock Holding History

Mirae Asset Global Investments’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3K Sell
3,512
-295
-8% -$1.6K ﹤0.01% 1513
2026
Q1 		$21.9K Buy
3,807
+260
+7% +$1.84K ﹤0.01% 1421
2025
Q4 		$35.2K Buy
3,547
+1,459
+70% +$13.3K ﹤0.01% 1467
2025
Q3 		$13.9K Buy
2,088
+806
+63% +$3.9K ﹤0.01% 1535
2025
Q2 		$5.15K Buy
1,282
+303
+31% +$996 ﹤0.01% 1538
2025
Q1 		$4.01K Sell
979
-123
-11% -$545 ﹤0.01% 1522
2024
Q4 		$7.47K Buy
+1,102
New +$8.68K ﹤0.01% 1534

Other funds holding LXEO

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
KFI
Key Financial Inc West Chester, Pennsylvania $611M AUM 21.11% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Mirae Asset Global Investments's LXEO Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Lexeo Therapeutics (LXEO) stake by 7.7% in Q2 2026, selling an estimated $1.6K and leaving 3,512 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1513.

Mirae Asset Global Investments first reported a position in LXEO in Q4 2024 and has held it in 7 quarters since. The position peaked at $35.2K in Q4 2025. 16 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • Mirae Asset Global Investments held 3,512 shares of Lexeo Therapeutics worth $16.3K as of Q2 2026.
  • Mirae Asset Global Investments sold 295 Lexeo Therapeutics shares in Q2 2026, an estimated $1.6K.
  • Lexeo Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1513 holding.
  • Mirae Asset Global Investments first reported a position in Lexeo Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Mirae Asset Global Investments's Lexeo Therapeutics position peaked at $35.2K in Q4 2025.
  • 16 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.